-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
At the recent policy briefing of the State Council, Chen Jinfu, deputy director of the National Medical Security Administration, introduced that the procurement of medicines and high-value medical consumables will be carried out in a normalized and institutionalized manner: promoting centralized procurement, speeding up and expanding coverage - centralized drug procurement in chemistry The three major sectors of medicine, Chinese patent medicine and biological medicine are carried out in an all-round way, and high-value medical consumables focus on orthopedic consumables, drug balloons, dental implants and other varieties
Chen Jinfu said that since 2018, the National Medical Insurance Administration, together with the relevant state departments, has promoted the reform of the procurement of medicines and high-value medical consumables by volume.
According to reports, judging from the results achieved, the centralized procurement rules have been continuously optimized, the quality supervision has become more rigorous, the supply guarantee has become more stable, and the use policy has become more complete
Chen Jinfu said that the next step will be to carry out the normalized and institutionalized procurement of medicines and high-value medical consumables with volume, and to promote the accelerated expansion of centralized procurement.
